These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 16757968
1. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression? Marshall SR. Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968 [Abstract] [Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
5. Treatment of graft versus host disease (GVHD) by photopheresis? Schooneman F, Claise C. Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550 [Abstract] [Full Text] [Related]
6. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Fimiani M, Di Renzo M, Rubegni P. Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889 [Abstract] [Full Text] [Related]
11. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C, Renoldi G, Parma M, Balduzzi A, Perseghin P, Biondi A. Transplantation; 2007 Jul 15; 84(1):31-9. PubMed ID: 17627234 [Abstract] [Full Text] [Related]
12. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis. Komanduri KV, Couriel D, Champlin RE. Biol Blood Marrow Transplant; 2006 Jan 15; 12(1 Suppl 2):1-6. PubMed ID: 16399595 [Abstract] [Full Text] [Related]
18. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD). Ayyildiz E, Arslan O, Topçuoğlu P, Arat M, Dalva K, Soydan EA, Tol M, Ilhan O. Transfus Apher Sci; 2007 Feb 15; 36(1):79-85. PubMed ID: 17234454 [Abstract] [Full Text] [Related]
19. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Kanold J, Messina C, Halle P, Locatelli F, Lanino E, Cesaro S, Deméocq F, Paediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant; 2005 Mar 15; 35 Suppl 1():S69-71. PubMed ID: 15812535 [Abstract] [Full Text] [Related]
20. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease. Kaloyannidis P, Mallouri D. Transfus Apher Sci; 2012 Apr 15; 46(2):211-9. PubMed ID: 22123355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]